Go Pro

USANA Health Sciences (USNA) Earnings Date, Estimates & Call Transcripts

USANA Health Sciences logo
$13.47 +0.29 (+2.20%)
As of 08/21/2026 03:58 PM Eastern

USANA Health Sciences Earnings Summary

USANA Health Sciences announced Q2 2026 earnings on August 4, 2026, reporting an EPS of -$0.07, which missed the consensus estimate of $0.43 by $0.50. Quarterly revenue was reported to be $223.27 million, below analyst estimates of $235 million. With a trailing EPS of -$1.21, USANA Health Sciences' earnings are expected to grow 132.89% next year, from $0.76 to $1.77 per share.

Upcoming Q3
Earnings Date
Oct. 28After Market ClosesEstimated
Consensus EPS
(Aug. 4)
$0.43
Actual EPS
(Aug. 4)
-$0.07 Missed By -$0.50
Actual Revenue
(Aug. 4)
$223.27M

Q2 2026 Earnings Resources

USNA Upcoming Earnings

USANA Health Sciences' next earnings date is estimated for Wednesday, October 28, 2026, based on past reporting schedules.

Get USANA Health Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

USNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

USNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

USANA Health Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20261$0.44$0.44$0.44
Q2 20261$0.43$0.43$0.43
Q3 20261$0.11$0.11$0.11
Q4 20261$0.11$0.11$0.11
FY 2026 4 $1.09 $1.09 $1.09
Q1 20271$0.34$0.34$0.34
Q2 20271$0.46$0.46$0.46
Q3 20271$0.47$0.47$0.47
Q4 20271$0.50$0.50$0.50

USANA Health Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/28/2026
(Estimated)
--------
8/4/2026Q2 2026$0.43-$0.07 -$0.50-$1.16$235.00M$223.27M
5/5/2026Q1 2026$0.44$0.61+$0.17$0.41$240.99M$250.22M
2/17/2026Q4 2025$0.41$0.60+$0.19-$0.10$225.96M$226.20M
10/22/2025Q3 2025$0.47-$0.15 -$0.62-$0.36$224.97M$213.67M
10/9/2025Q3 2025-$0.56---$200.22M
7/22/2025Q2 2025$0.54$0.74+$0.20$0.52$225.20M$235.85M
4/22/2025Q1 2025$0.70$0.73+$0.03$0.49$243.08M$249.54M
2/25/2025Q4 2024$0.49$0.64+$0.15$0.23$208.82M$213.61M
10/22/2024Q3 2024$0.49$0.56+$0.07$0.56$208.45M$200.22M

USANA Health Sciences Earnings - Frequently Asked Questions

USANA Health Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 28th, 2026 based off last year's report dates. Learn more on USNA's earnings history.

USANA Health Sciences updated its FY 2026 earnings guidance on Tuesday, August, 4th. The company provided earnings per share (EPS) guidance of 0.760-0.760 for the period, compared to the consensus estimate of 2.120. The company issued revenue guidance of $910.0 million-$910.0 million, compared to the consensus revenue estimate of $945.1 million.

In the previous quarter, USANA Health Sciences (NYSE:USNA) missed the analysts' consensus estimate of $0.43 by $0.50 with a reported earnings per share (EPS) of ($0.07). Learn more on analysts' earnings estimate vs. USNA's actual earnings.

The conference call for USANA Health Sciences' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for USANA Health Sciences' latest earnings report can be read online.
Read Transcript

USANA Health Sciences (NYSE:USNA) has a recorded annual revenue of $925.26 million.

USANA Health Sciences (NYSE:USNA) has a recorded net income of $10.76 million. USNA has generated -$1.21 earnings per share over the last four quarters.

USANA Health Sciences (NYSE:USNA) has a forward price-to-earnings ratio of 17.72. The price/earnings-to-growth ratio is 1.49.

USANA Health Sciences' earnings are expected to grow from $0.76 per share to $1.77 per share in the next year, which is a 132.89% increase.


Earnings data for NYSE:USNA is sourced from Fiscal.ai, with the most recent quarter reported on 8/4/2026. New results are added as companies report their earnings.
From Our Partners